Jeffrey Yu Purchases 142,857 Shares of OneMedNet (NASDAQ:ONMD) Stock

OneMedNet Corporation (NASDAQ:ONMDGet Free Report) insider Jeffrey Yu bought 142,857 shares of the business’s stock in a transaction on Thursday, September 10th. The stock was purchased at an average price of $0.63 per share, for a total transaction of $89,999.91. Following the completion of the acquisition, the insider owned 8,923,267 shares of the company’s stock, valued at approximately $5,621,658.21. This trade represents a 1.63% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Jeffrey Yu also recently made the following trade(s):

  • On Tuesday, June 23rd, Jeffrey Yu acquired 158,730 shares of OneMedNet stock. The stock was bought at an average cost of $0.63 per share, with a total value of $99,999.90.
  • On Tuesday, June 16th, Jeffrey Yu bought 172,414 shares of OneMedNet stock. The stock was acquired at an average cost of $0.58 per share, with a total value of $100,000.12.

OneMedNet Price Performance

Shares of OneMedNet stock traded up $0.02 during trading on Monday, reaching $0.67. 244,221 shares of the company’s stock were exchanged, compared to its average volume of 270,916. The firm’s 50-day moving average price is $0.66 and its 200 day moving average price is $0.75. OneMedNet Corporation has a 1-year low of $0.49 and a 1-year high of $4.22.

OneMedNet (NASDAQ:ONMDGet Free Report) last announced its earnings results on Friday, August 14th. The company reported ($0.04) EPS for the quarter. The company had revenue of $0.29 million during the quarter.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ONMD. Wall Street Zen cut OneMedNet from a “hold” rating to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings upgraded OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

View Our Latest Stock Report on OneMedNet

About OneMedNet

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Further Reading

Insider Buying and Selling by Quarter for OneMedNet (NASDAQ:ONMD)

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.